Where does Exela Pharma Sciences, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Exela Pharma Sciences, LLC ranks #13,982 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Exela Pharma Sciences, LLC hold?

Exela Pharma Sciences, LLC holds 21 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Exela Pharma Sciences, LLC's Innovation Score?

Exela Pharma Sciences, LLC has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Exela Pharma Sciences, LLC focus on?

Exela Pharma Sciences, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 21 patents, ranking #1,078 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Exela Pharma Sciences, LLC's patent grant rate increasing or decreasing?

Exela Pharma Sciences, LLC's recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Exela Pharma Sciences, LLC's patents?

Exela Pharma Sciences, LLC's patents average 26.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Exela Pharma Sciences, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Exela Pharma Sciences, LLC

USPTO PatentsView assignee record - 21 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exela ranks #13,982 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 5 technology areas.

#13,982
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 26.9
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13982 · US Corporation #13,982 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,982/49,997
PHOTO-FINISH Ecole Normale…
CPC-NARROW A61K · 5 areas
INNOV-PAR 42.8/100
CLAIMS-DENSE 26.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ecole Normale Superieure De Cachan (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exela’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (25%) Velocity 9.2 pts (21%) Breadth 7.9 pts (18%) Claim depth 15.0 pts (35%)

Qualcomm Incorporated · highest

85
Exela Pharma Sciences · this assignee

43
3D Lighting… · lowest

7

What this shows Exela's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exela?

Each dot is one of Exela’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exela’s own 26.9 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Exela vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exela's grants concentrate

Exela Pharma Sciences, LLC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (7 grants) versus a trough of 1 in 2016. By volume, Exela sits between Empi Inc. and Emboline, Inc..

Exela's three-year grant acceleration

Exela Pharma Sciences, LLC shows 11 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Empi

21
Epigenomics

21
Erae AMS

21
Ewald DÖRKEN

21
Ecole Normale Sup…

21
Imaging Services

21
Elsevier

21
Emboline

21
Exela Pharma Scie… ◀

21

What this shows Exela holds 21 patents at rank #13,965, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Exela

By rank, the assignees closest to #13,965 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Exela's primary technology class.

Exela's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Exela Pharma Sciences, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	4.8%
2019	1	4.8%
2020	2	9.5%
2021	5	23.8%
2022	2	9.5%
2023	7	33.3%
2024	2	9.5%
2025partial year	1	4.8%

Which technologies does Exela Pharma Sciences, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 21

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 19

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 19

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 19

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Exela Pharma Sciences, LLC's patent record in context - here's where to go next.

Exela Pharma Sciences, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #13,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Exela Pharma Sciences, LLC against Empi Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.